Evidence-based Lifestyle Interventions for the Delay of Cognitive Decline Among Older Singaporeans
2 other identifiers
interventional
120
1 country
2
Brief Summary
The investigators aim to investigate the relationship between lifestyle factors and cognitive decline among older Singaporeans and assess the feasibility and preliminary efficacy of a lifestyle intervention programme in delaying cognitive decline. Healthy lifestyle is a way of living that can lower down disease risk and promote health and wellbeing. Accumulating evidences support that lifestyle factors contribute to the development of dementia and hence modifying lifestyle could be a promising approach for dementia prevention. The intervention will focus on the promotion of a brain-healthy lifestyle, with special attention paid to common problems among local older adults. The investigators will assess cognitive and biological changes using the following outcome measures. Primary outcome: the processing speed domain Z score derived from raw scores of three tests including the symbol digit modality test, Colour trial test, and Stroop test (condition 2). Secondary outcome: i. epigenetic age (DNA methylation), ii. plasma-based markers of inflammation, iii. activities of daily living and instrumental activities of daily living, iv. Health-related quality of life measured by the EQ-5D-5L scale, v. wellbeing measured by the ICECAP-O (ICEpop CAPability measure for Older people), vi. other neurocognitive assessment tests. The investigators hypothesize that:
- 1.Lifestyle factors are associated with cognitive decline, epigenetic age, and systematic chronic inflammation.
- 2.Evidence-based lifestyle intervention focusing on common problems among local population can delay cognitive decline, slow epigenetic ageing, and produce favorable changes on chronic systemic inflammation.
- 3.Changes in biological markers will correlate with changes in cognitive function, and hence partially explains the observed clinical efficacy.
- 4.The interventions may also improve daily functioning, health-related quality of life, and wellbeing.
- 5.Interventions delivered in an individualized manner would produce more benefits than interventions delivered uniformly without considering individual's risk profile and personal and social context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
ExpectedApril 8, 2026
April 1, 2026
1.5 years
June 24, 2024
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Standard Neuropsychological Tests of Information Processing Speed
The primary outcome of the trial is the processing speed, measured using the average of domain Z score derived from raw scores of three tests including the symbol digit modality test, colour trial test (Condition A) and Stroop test (Condition 2). The average of Z scores standardised to the baseline mean and standard deviation of trial participants, with higher scores representing better processing speed.
Cognitive assessment will be conducted at three timepoints within 2 years period, baseline, 12 months and 24 months
Secondary Outcomes (17)
Biological Outcome
All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months
Biological Outcome
All of the outcome meausures will be measured at three timepoints including baseline, 12 months and 24 months
Quality of life Outcome
All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months
Quality of life Outcome
All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months
Social Support Outcome
All of the outcome measures will be measured at three timepoints including baseline, 12 months and 24 months
- +12 more secondary outcomes
Study Arms (3)
Control group
NO INTERVENTIONThe control group will not receive any intervention and, is only required to attend 3 timepoints of cognitive assessment: baseline, 12 months and 24 months.
Uniformed intervention group
EXPERIMENTALUniformed intervention groups receive health education sessions in a group setting. Each session is one hour, and lifestyle health-related topics will be delivered to the participants for their knowledge.
Individualised intervention group
ACTIVE COMPARATORThe individualised intervention group receives health education sessions as the uniformed intervention group and receives additional one-on-one health coaching, which besides the group sessions, the participants receive individual sessions every three months.
Interventions
The investigators provide lifestyle intervention through a health education programme which is in a group setting. The sessions consisted of short talks on a health-related topic targeting lifestyle factors associated with dementia risk, followed by group activities that required interactions, cognitive engagement, and the acquisition of certain skills (for example, how to read food labels, how to measure blood pressure, how to recognize signs of depression, et al).
On top of the uniformed intervention group, the individualised intervention group receives also 1:1 sessions every 3 months within 2 years. Participants will review the knowledge taught in the group sessions individually and the investigator will address the participant's concerns and provide advice to the participant for a better lifestyle accordingly.
Eligibility Criteria
You may qualify if:
- (1) Age 60-75 years;
- (2) Singapore Modified Mini-Mental State Examination total score lower than locally validated education-specific cutoffs: \< 25, 27 and 29 for those with nil, primary and secondary school and above education levels, respectively66.
- (3) Non-demented (Clinical Dementia Rating global score = 0).
You may not qualify if:
- Conditions preventing effective engagement in the intervention
- (1) Terminal illness, aphasia
- (2) Marked hearing impairment
- (3) Participation in another interventional study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
National University Singapore, Tahir Foundation Building
Singapore, Singapore, 117549, Singapore
National University Singapore
Singapore, Singapore, 119228, Singapore
Related Publications (3)
Liu LY, Lu Y, Shen L, Li CB, Yu JT, Yuan CR, Ye KX, Chao YX, Shen QF, Mahendran R, Kua EH, Yu DH, Feng L. Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly. J Psychiatr Res. 2022 Jan;145:111-117. doi: 10.1016/j.jpsychires.2021.11.041. Epub 2021 Nov 25.
PMID: 34894520BACKGROUNDYe KX, Sun L, Wang L, Khoo ALY, Lim KX, Lu G, Yu L, Li C, Maier AB, Feng L. The role of lifestyle factors in cognitive health and dementia in oldest-old: A systematic review. Neurosci Biobehav Rev. 2023 Sep;152:105286. doi: 10.1016/j.neubiorev.2023.105286. Epub 2023 Jun 13.
PMID: 37321363BACKGROUNDWu DX, Feng L, Yao SQ, Tian XF, Mahendran R, Kua EH. The early dementia prevention programme in Singapore. Lancet Psychiatry. 2014 Jun;1(1):9-11. doi: 10.1016/S2215-0366(14)70233-0. Epub 2014 Jun 4. No abstract available.
PMID: 26360390BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 24, 2024
First Posted
October 28, 2024
Study Start
October 1, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
April 1, 2028
Last Updated
April 8, 2026
Record last verified: 2026-04